Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07029607 · ClinicalTrials.gov registry record · NA
A Randomized Double Blind, Placebo Controlled Clinical Study Evaluating the Efficacy and Safety of Magnesium Supplementation on Relaxation in Adults
A NA study, sponsored by Olly, PBC.
- Not yet
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT07029607: Clinical Trial NA study, sponsored by Olly, PBC.
NCT07029607 is a NA study that has not yet begun recruiting, run by Olly, PBC. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07029607, a NA study, has not yet begun recruiting, sponsored by Olly, PBC.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
The study will assess the efficacy of magnesium supplementation for improvement of body and mind relaxation (through stress levels), and sleep score compared to placebo, assessed by validated questionnaires. Participants will be asked to take the supplement every day for 12 weeks and will complete monthly check-ins and questionnaires. Participants will monitor adverse events in a journal.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Dietary Supplement with actives
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2025-07-14 |
| Est. Completion | 2025-10-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07029607
The ClinicalTrials.gov registry entry for NCT07029607 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Olly, PBC, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT07029607 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07029607 about?
NCT07029607 is a clinical study titled "A Randomized Double Blind, Placebo Controlled Clinical Study Evaluating the Efficacy and Safety of Magnesium Supplementation on Relaxation in Adults". The study will assess the efficacy of magnesium supplementation for improvement of body and mind relaxation (through stress levels), and sleep score compared to placebo, assessed by validated questionnaires. Participants will be asked to take the supplement every day for 12 weeks and will complete m...
What is the current status of trial NCT07029607?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2025-07-14. Estimated completion is 2025-10-24.
What interventions are being tested in trial NCT07029607?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Dietary Supplement with actives (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07029607?
This trial is sponsored by Olly, PBC, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.